Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Treatment results for children and adolescents with acute myeloid leukemia in Middle and Eastern European countries

Treatment results for children and adolescents with acute myeloid leukemia in Middle and Eastern... editorial memo (2013) 6:5–8 DOI 10.1007/s12254-013-0070-3 Treatment results for children and adolescents with acute myeloid leukemia in Middle and Eastern European countries Ursula Creutzig, Gesche Tallen Received: 14 January 2013 / Accepted: 21 January 2013 / Published online: 15 February 2013 © Springer-Verlag Wien 2013 Ursula Creutzig Acute myeloid leukemia (AML) corresponds to a hetero- The key of success in treating pediatric leukemias in geneous group of hematologic neoplasms that originate high-income Western European countries during the from bone marrow precursors of the myeloid, mono- past decades has been the conduct of clinical studies, cyte, erythroid, and megakaryocytic cell lineages. While the concept of which is based on the comparative testing acute lymphoblastic leukemia (ALL) remains the most of the effectiveness of multimodal treatment concepts common childhood malignancy, AML comprises only (rather than on studying the efficacy of a single drug) as about 4.8  % of all pediatric cancers in Europe. However, well as on patient stratification into specific risk groups although an orphan disease and despite of remarkable according to the individual morphology, histochemistry, advances during the past decades in both the manage- immunophenotype and genetic subtype of the disease. ment and the understanding of the biology and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

Treatment results for children and adolescents with acute myeloid leukemia in Middle and Eastern European countries

Download PDF
4 pages

Loading next page...
 
/lp/springer-journals/treatment-results-for-children-and-adolescents-with-acute-myeloid-PJdYsXgtOe

References (19)

Publisher
Springer Journals
Copyright
Copyright © 2013 by Springer-Verlag Wien
Subject
Medicine & Public Health; Oncology; Medicine/Public Health, general
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-013-0070-3
Publisher site
See Article on Publisher Site

Abstract

editorial memo (2013) 6:5–8 DOI 10.1007/s12254-013-0070-3 Treatment results for children and adolescents with acute myeloid leukemia in Middle and Eastern European countries Ursula Creutzig, Gesche Tallen Received: 14 January 2013 / Accepted: 21 January 2013 / Published online: 15 February 2013 © Springer-Verlag Wien 2013 Ursula Creutzig Acute myeloid leukemia (AML) corresponds to a hetero- The key of success in treating pediatric leukemias in geneous group of hematologic neoplasms that originate high-income Western European countries during the from bone marrow precursors of the myeloid, mono- past decades has been the conduct of clinical studies, cyte, erythroid, and megakaryocytic cell lineages. While the concept of which is based on the comparative testing acute lymphoblastic leukemia (ALL) remains the most of the effectiveness of multimodal treatment concepts common childhood malignancy, AML comprises only (rather than on studying the efficacy of a single drug) as about 4.8  % of all pediatric cancers in Europe. However, well as on patient stratification into specific risk groups although an orphan disease and despite of remarkable according to the individual morphology, histochemistry, advances during the past decades in both the manage- immunophenotype and genetic subtype of the disease. ment and the understanding of the biology and

Journal

memo - Magazine of European Medical Oncology – Springer Journals

Published: Feb 15, 2013

There are no references for this article.